Trade publication Capitol Forum first reported the news.
In an earnings call April 5, Walgreens Boots Alliance Executive Vice Chairman and CEO Stefano Pessina said he was “optimistic” the deal would receive regulatory approval. To reach the revised agreement’s July 31 deadline, Walgreens issued a declaration of “certified compliance,” giving the FTC three months to issue a final decision on the proposed transaction.
The FTC expressed concerns during their initial review of the deal, arguing the proposed transaction would be anticompetitive.
The companies initially proposed the acquisition agreement in October 2015.
More articles on transactions and valuations:
Cleveland Clinic, University of Nevada, Las Vegas discuss expanding partnership
Yuma Regional Medical Center partners with Accumen on critical laboratory initiatives
VA partners with CVS to reduce patient wait times in Phoenix
